Cargando…
Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy
PURPOSE: Although the combined photo-thermal (PTT) and photodynamic therapy (PDT) of tumors have demonstrated promise as effective cancer therapy, the hypoxic and insufficient H(2)O(2) supply of tumors seriously limits the efficacy of PDT, and the acidic environment reduces the catalytic activity of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327690/ https://www.ncbi.nlm.nih.gov/pubmed/37427365 http://dx.doi.org/10.2147/IJN.S387505 |
_version_ | 1785069680781688832 |
---|---|
author | Li, Zhengzhao Guo, Lianshan Lin, Liqiao Wang, Tongting Jiang, Yanqiu Song, Jin Feng, Jihua Huang, Jianfeng Li, Haoyu Bai, Zhihao Liu, Wenqi Zhang, Jianfeng |
author_facet | Li, Zhengzhao Guo, Lianshan Lin, Liqiao Wang, Tongting Jiang, Yanqiu Song, Jin Feng, Jihua Huang, Jianfeng Li, Haoyu Bai, Zhihao Liu, Wenqi Zhang, Jianfeng |
author_sort | Li, Zhengzhao |
collection | PubMed |
description | PURPOSE: Although the combined photo-thermal (PTT) and photodynamic therapy (PDT) of tumors have demonstrated promise as effective cancer therapy, the hypoxic and insufficient H(2)O(2) supply of tumors seriously limits the efficacy of PDT, and the acidic environment reduces the catalytic activity of nanomaterial in the tumor microenvironment. To develop a platform for efficiently addressing these challenges, we constructed a nanomaterial of Aptamer@dox/GOD-MnO(2)-SiO(2)@HGNs-Fc@Ce6 (AMS) for combination tumor therapy. The treatment effects of AMS were evaluated both in vitro and in vivo. METHODS: In this work, Ce6 and hemin were loaded on graphene (GO) through π-π conjugation, and Fc was connected to GO via amide bond. The HGNs-Fc@Ce6 was loaded into SiO(2), and coated with dopamine. Then, MnO(2) was modified on the SiO(2). Finally, AS1411-aptamer@dox and GOD were fixed to gain AMS. We characterized the morphology, size, and zeta potential of AMS. The oxygen and reactive oxygen species (ROS) production properties of AMS were analyzed. The cytotoxicity of AMS was detected by MTT and calcein-AM/PI assays. The apoptosis of AMS to a tumor cell was estimated with a JC-1 probe, and the ROS level was detected with a 2’,7’-Dichlorodihydrofluorescein diacetate (DCFH-DA) probe. The anticancer efficacy in vivo was analyzed by the changes in the tumor size in different treatment groups. RESULTS: AMS was targeted to the tumor cell and released doxorubicin. It decomposed glucose to produce H(2)O(2) in the GOD-mediated reaction. The generated sufficient H(2)O(2) was catalyzed by MnO(2) and HGNs-Fc@Ce6 to produce O(2) and free radicals (•OH), respectively. The increased oxygen content improved the hypoxic environment of the tumor and effectively reduced the resistance to PDT. The generated •OH enhanced the ROS treatment. Moreover, AMS depicted a good photo-thermal effect. CONCLUSION: The results revealed that AMS had an excellent enhanced therapy effect by combining synergistic PTT and PDT. |
format | Online Article Text |
id | pubmed-10327690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103276902023-07-08 Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy Li, Zhengzhao Guo, Lianshan Lin, Liqiao Wang, Tongting Jiang, Yanqiu Song, Jin Feng, Jihua Huang, Jianfeng Li, Haoyu Bai, Zhihao Liu, Wenqi Zhang, Jianfeng Int J Nanomedicine Original Research PURPOSE: Although the combined photo-thermal (PTT) and photodynamic therapy (PDT) of tumors have demonstrated promise as effective cancer therapy, the hypoxic and insufficient H(2)O(2) supply of tumors seriously limits the efficacy of PDT, and the acidic environment reduces the catalytic activity of nanomaterial in the tumor microenvironment. To develop a platform for efficiently addressing these challenges, we constructed a nanomaterial of Aptamer@dox/GOD-MnO(2)-SiO(2)@HGNs-Fc@Ce6 (AMS) for combination tumor therapy. The treatment effects of AMS were evaluated both in vitro and in vivo. METHODS: In this work, Ce6 and hemin were loaded on graphene (GO) through π-π conjugation, and Fc was connected to GO via amide bond. The HGNs-Fc@Ce6 was loaded into SiO(2), and coated with dopamine. Then, MnO(2) was modified on the SiO(2). Finally, AS1411-aptamer@dox and GOD were fixed to gain AMS. We characterized the morphology, size, and zeta potential of AMS. The oxygen and reactive oxygen species (ROS) production properties of AMS were analyzed. The cytotoxicity of AMS was detected by MTT and calcein-AM/PI assays. The apoptosis of AMS to a tumor cell was estimated with a JC-1 probe, and the ROS level was detected with a 2’,7’-Dichlorodihydrofluorescein diacetate (DCFH-DA) probe. The anticancer efficacy in vivo was analyzed by the changes in the tumor size in different treatment groups. RESULTS: AMS was targeted to the tumor cell and released doxorubicin. It decomposed glucose to produce H(2)O(2) in the GOD-mediated reaction. The generated sufficient H(2)O(2) was catalyzed by MnO(2) and HGNs-Fc@Ce6 to produce O(2) and free radicals (•OH), respectively. The increased oxygen content improved the hypoxic environment of the tumor and effectively reduced the resistance to PDT. The generated •OH enhanced the ROS treatment. Moreover, AMS depicted a good photo-thermal effect. CONCLUSION: The results revealed that AMS had an excellent enhanced therapy effect by combining synergistic PTT and PDT. Dove 2023-07-03 /pmc/articles/PMC10327690/ /pubmed/37427365 http://dx.doi.org/10.2147/IJN.S387505 Text en © 2023 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Zhengzhao Guo, Lianshan Lin, Liqiao Wang, Tongting Jiang, Yanqiu Song, Jin Feng, Jihua Huang, Jianfeng Li, Haoyu Bai, Zhihao Liu, Wenqi Zhang, Jianfeng Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title | Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title_full | Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title_fullStr | Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title_full_unstemmed | Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title_short | Porous SiO(2)-Based Reactor with Self-Supply of O(2) and H(2)O(2) for Synergistic Photo-Thermal/Photodynamic Therapy |
title_sort | porous sio(2)-based reactor with self-supply of o(2) and h(2)o(2) for synergistic photo-thermal/photodynamic therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327690/ https://www.ncbi.nlm.nih.gov/pubmed/37427365 http://dx.doi.org/10.2147/IJN.S387505 |
work_keys_str_mv | AT lizhengzhao poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT guolianshan poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT linliqiao poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT wangtongting poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT jiangyanqiu poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT songjin poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT fengjihua poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT huangjianfeng poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT lihaoyu poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT baizhihao poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT liuwenqi poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy AT zhangjianfeng poroussio2basedreactorwithselfsupplyofo2andh2o2forsynergisticphotothermalphotodynamictherapy |